Not every stock is hitting fresh highs. These two companies you know are cheap in an otherwise ascending market.

Revenue cycle management leaders know that the battle for financial performance is increasingly being fought at the intersection of clinical accuracy and operational speed. As denials rise and margins ...

The move in silver picks up steam… why more gains are likely… the latest trade winner from Jonathan Rose… why it still has legs… Eric Fry says it’s time to sell Amazon – what he’s buying to replace it ...

FQ2 earnings report affirmed the outlook for long-term share price increases, as indicated by the recent stock split. Due to their quality, stocks that split tend to trend higher over time, ...